Kukje Pharma Co Ltd (002720) — Capital Reinvestment Ratio
Latest as of September 2025:
0.10x
Kukje Pharma Co Ltd (002720) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩4.99 Billion) in capital expenditures (₩474.52 Million). See 002720 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.10x
Capex / Operating Cash Flow
Operating Cash Flow
₩4.99 Billion
KRW
Capital Expenditures
₩474.52 Million
KRW
Data as of
Sep 2025
Most recent filing
Kukje Pharma Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Kukje Pharma Co Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Kukje Pharma Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Kukje Pharma Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see 002720 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.76x | ₩3.94 Billion | ₩2.99 Billion | ▲ +159.8% |
| 2023 | 0.29x | ₩3.58 Billion | ₩1.05 Billion | ▲ +51.1% |
| 2022 | 0.19x | ₩6.50 Billion | ₩1.26 Billion | ▼ -1.8% |
| 2021 | 0.20x | ₩9.60 Billion | ₩1.89 Billion | ▼ -91.3% |
| 2020 | 2.27x | ₩5.10 Billion | ₩11.60 Billion | ▲ +39.2% |
| 2019 | 1.63x | ₩3.60 Billion | ₩5.89 Billion | ▲ +615.1% |
| 2018 | 0.23x | ₩13.25 Billion | ₩3.03 Billion | ▼ -93.1% |
| 2017 | 3.32x | ₩786.10 Million | ₩2.61 Billion | ▲ +1889.6% |
| 2016 | 0.17x | ₩16.10 Billion | ₩2.69 Billion | ▼ -83.4% |
| 2012 | 1.00x | ₩1.58 Billion | ₩1.59 Billion | ▲ +1641.9% |
| 2011 | 0.06x | ₩17.39 Billion | ₩1.00 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow